Fifth Third Wealth Advisors’s Roivant Sciences ROIV Stock Holding History

Fifth Third Wealth Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$380K	Buy	10,744 +578	+6%	+$17.1K	0.01%	598
2026 Q1	$282K	Buy	10,166 +445	+5%	+$11.4K	0.01%	634
2025 Q4	$211K	Buy	+9,721	New	+$192K	0.01%	736
2024 Q3	–	Sell	-9,535	Closed	-$101K	–	725
2024 Q2	$101K	Buy	+9,535	New	+$104K	0.01%	656

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Fifth Third Wealth Advisors's ROIV Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Roivant Sciences (ROIV) stake by 5.7% in Q2 2026, buying an estimated $17.1K and bringing the position to 10,744 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #598.

Fifth Third Wealth Advisors first reported a position in ROIV in Q2 2024 and has held it in 4 quarters since. 52 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Fifth Third Wealth Advisors held 10,744 shares of Roivant Sciences worth $380K as of Q2 2026.
Fifth Third Wealth Advisors bought 578 Roivant Sciences shares in Q2 2026, an estimated $17.1K.
Roivant Sciences made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #598 holding.
Fifth Third Wealth Advisors first reported a position in Roivant Sciences in Q2 2024 and has held it in 4 quarters since.
52 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.